These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36673825)

  • 1. Evidence on Neurotoxicity after Intrauterine and Childhood Exposure to Organomercurials.
    Azevedo LF; Karpova N; Rocha BA; Barbosa Junior F; Gobe GC; Hornos Carneiro MF
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of ethylmercury (and Thimerosal): a comparison with methylmercury.
    Dórea JG; Farina M; Rocha JB
    J Appl Toxicol; 2013 Aug; 33(8):700-11. PubMed ID: 23401210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A brain proteome profile in rats exposed to methylmercury or thimerosal (ethylmercury).
    de Oliveira Souza VC; de Marco KC; Laure HJ; Rosa JC; Barbosa F
    J Toxicol Environ Health A; 2016; 79(12):502-12. PubMed ID: 27294299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice.
    Berman RF; Pessah IN; Mouton PR; Mav D; Harry J
    Toxicol Sci; 2008 Feb; 101(2):294-309. PubMed ID: 17977901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response analysis indicating time-dependent neurotoxicity caused by organic and inorganic mercury-Implications for toxic effects in the developing brain.
    Pletz J; Sánchez-Bayo F; Tennekes HA
    Toxicology; 2016 Mar; 347-349():1-5. PubMed ID: 26945727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiol-modulated mechanisms of the cytotoxicity of thimerosal and inhibition of DNA topoisomerase II alpha.
    Wu X; Liang H; O'Hara KA; Yalowich JC; Hasinoff BB
    Chem Res Toxicol; 2008 Feb; 21(2):483-93. PubMed ID: 18197631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants.
    Magos L
    J Appl Toxicol; 2003; 23(4):263-9. PubMed ID: 12884410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and distribution of mercury species in rat tissues following administration of thimerosal or methylmercury.
    Rodrigues JL; Serpeloni JM; Batista BL; Souza SS; Barbosa F
    Arch Toxicol; 2010 Nov; 84(11):891-6. PubMed ID: 20386881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
    Parker SK; Schwartz B; Todd J; Pickering LK
    Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abating Mercury Exposure in Young Children Should Include Thimerosal-Free Vaccines.
    Dórea JG
    Neurochem Res; 2017 Oct; 42(10):2673-2685. PubMed ID: 28439753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal.
    Burbacher TM; Shen DD; Liberato N; Grant KS; Cernichiari E; Clarkson T
    Environ Health Perspect; 2005 Aug; 113(8):1015-21. PubMed ID: 16079072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxic effects of combined exposures to aluminum and mercury in early life (infancy).
    Dórea JG
    Environ Res; 2020 Sep; 188():109734. PubMed ID: 32544722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethylmercury and breastfeeding as confounders in outcomes of functional programming: Where are they?
    Dórea JG
    Reprod Toxicol; 2008 Jan; 25(1):133; author reply 134. PubMed ID: 18065193
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcriptomic analyses of neurotoxic effects in mouse brain after intermittent neonatal administration of thimerosal.
    Li X; Qu F; Xie W; Wang F; Liu H; Song S; Chen T; Zhang Y; Zhu S; Wang Y; Guo C; Tang TS
    Toxicol Sci; 2014 Jun; 139(2):452-65. PubMed ID: 24675092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ
    Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ; McIntyre PB
    Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
    Dórea JG; Marques RC
    Toxicol Sci; 2008 Jun; 103(2):414-5; author reply 416. PubMed ID: 18364366
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose Thimerosal (ethyl-mercury) is still used in infants` vaccines: Should we be concerned with this form of exposure?
    Dórea JG
    J Trace Elem Med Biol; 2018 Sep; 49():134-139. PubMed ID: 29895363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the evidence that ethylmercury crosses the blood-brain barrier.
    Kern JK; Geier DA; Homme KG; Geier MR
    Environ Toxicol Pharmacol; 2020 Feb; 74():103312. PubMed ID: 31841767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.